Navigating the treatment landscape in multiple myeloma: which combinations to use and when? Hartmut GoldschmidtJohn AshcroftLaurent Garderet Review Article Open access 23 November 2018 Pages: 1 - 18
Glucocorticoids in multiple myeloma: past, present, and future Nicholas BurwickSanjai Sharma Review Article 02 August 2018 Pages: 19 - 28
Incidence and treatment outcome of aplastic anemia in Taiwan—real-world data from single-institute experience and a nationwide population-based database Sin-Syue LiYa-Ting HsuTsai-Yun Chen Original Article 03 September 2018 Pages: 29 - 39
Immunosuppressive therapy for aplastic anemia: a single-center experience from western India Sandip ShahPreetam JainAsha Anand Original Article Open access 01 September 2018 Pages: 41 - 46
Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns Stephan LobitzJeannette KleinClaudia Frömmel Original Article 21 August 2018 Pages: 47 - 53
National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality Ersi VoskaridouAntonis Kattamison behalf of the Greek Haemoglobinopathies Study Group Original Article 08 September 2018 Pages: 55 - 66
Hemophagocytic syndrome in patients living with HIV: a retrospective study João Paulo TellesMarina de Andrade PerezWalter Moises Tobias Original Article 25 September 2018 Pages: 67 - 72
Classifying AML patients with inv(16) into high-risk and low-risk relapsed patients based on peritransplantation minimal residual disease determined by CBFβ/MYH11 gene expression Zhao XiaosuCao LeqingChang Yingjun Original Article 29 August 2018 Pages: 73 - 81
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study Naomi KawashimaAkimi Akashifor the Japan Adult Leukemia Study Group (JALSG) Original Article 24 September 2018 Pages: 83 - 91
High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation Kai WilleParvis SadjadianMartin Griesshammer Original Article 28 August 2018 Pages: 93 - 100
Cardiovascular disease in chronic myelomonocytic leukemia: do monocytosis and chronic inflammation predispose to accelerated atherosclerosis? Mette Vestergaard ElbækAnders Lindholm SørensenHans Carl Hasselbalch Original Article 04 September 2018 Pages: 101 - 109
Next-generation sequencing for JAK2 mutation testing: advantages and pitfalls Nabih MaslahEmmanuelle VergerBruno Cassinat Original Article 26 September 2018 Pages: 111 - 118
Autopsy findings in patients with acute myeloid leukemia and non-Hodgkin lymphoma in the modern era: a focus on lung pathology and acute respiratory failure Andry Van de LouwAllyson M. LewisZhaohai Yang Original Article 14 September 2018 Pages: 119 - 129
Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma Dai MaruyamaKunihiro TsukasakiKensei Tobinai Original Article Open access 05 July 2018 Pages: 131 - 142
Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China Yan ZhangWei ZhangDaobin Zhou Original Article 12 September 2018 Pages: 143 - 150
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party Sung-Hoon JungSe-ryeon LeeHo-Jin Shin Original Article 26 September 2018 Pages: 151 - 158
Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors Anthony S. SteinGary SchillerMax S. Topp Original Article Open access 20 September 2018 Pages: 159 - 167
MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type Anahita NosratiAhmad MonabatiSajjadeh Movahedinia Original Article 11 October 2018 Pages: 169 - 173
Burden of illness of follicular lymphoma and marginal zone lymphoma Neerav MongaLoretta NastoupilCatherine Thieblemont Original Article 13 October 2018 Pages: 175 - 183
Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies Xiao-Ning GaoJi LinDai-Hong Liu Original Article Open access 24 August 2018 Pages: 185 - 193
Intensive care unit admission in patients with T cell lymphomas: clinical features and outcome Guillaume DumasLucie BiardEmmanuel Canet Original Article 14 September 2018 Pages: 195 - 203
Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib David WannerJan-Paul BohnMichael Steurer Letter to the Editor 26 May 2018 Pages: 205 - 207
Major bleeding in a patient with warfarin-hypersensitive and factor IX propeptide variant, p.Ala37Thr, who was treated with a direct oral anti-Xa inhibitor Asako TamuraHideo WadaHidekazu Tomimoto Letter to the Editor 19 June 2018 Pages: 209 - 210
Cytogenetically cryptic insertion of PML segment into RARA on chromosome 17q resulting PML-RARA fusion in acute promyelocytic leukemia Timothy F. BurnsEric Y. LooLiming Bao Letter to the Editor 20 July 2018 Pages: 211 - 213
Risk of viral reactivation in patients with occult hepatitis B virus infection during ruxolitinib treatment Harinder GillGarret M. K. LeungYok-Lam Kwong Letter to the Editor 26 June 2018 Pages: 215 - 218
γδ T cell clonal proliferation early after PD-1 blockade Koya OnoYasushi OnishiHideo Harigae Letter to the Editor 26 June 2018 Pages: 219 - 220
Acute myeloid leukemia with t(19;21)(q13;q22) and marked eosinophilia Yasushi KubotaKazuharu KamachiShinya Kimura Letter to the Editor 27 June 2018 Pages: 221 - 222
Next-generation sequencing identified a novel SPTB frameshift insertion causing hereditary spherocytosis in China Lan-Lan MengShi-Min YuanYue-Qiu Tan Letter to the Editor 01 July 2018 Pages: 223 - 226
Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient Clemens HinterleitnerMartina SteurerMartin R. Müller Letter to the Editor 06 July 2018 Pages: 227 - 230
Langerhans cell histiocytosis associated with classical Hodgkin lymphoma contains BRAF V600E mutation Shanxiang ZhangJulia SteinhilberFalko Fend Letter to the Editor 12 July 2018 Pages: 231 - 233
Cytotoxic T-lymphocyte-associated antigen 4-positive aggressive adult T cell leukemia/lymphoma Sanae SuedaShoko NakayamaMitsuhiro Matsuda Letter to the Editor 06 July 2018 Pages: 235 - 236
Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation Tae Kon KimMichelle DeVeauxStuart Seropian Letter to the Editor 19 July 2018 Pages: 237 - 240